Literature DB >> 480161

High-pressure liquid chromatographic analysis of antipyrine in small plasma samples.

L Shargel, W M Cheung, A B Yu.   

Abstract

A high-pressure liquid chromatographic (HPLC) method was developed for the assay of antipyrine in small (0.1-ml) plasma samples using aminopyrine as the internal standard and a reversed-phase microparticulate column. The assay sensitivity (1 microgram/ml) permits development of a plasma level--time curve using a single rat. The mean (+/- SE) plasma elmination half-life in rats was 1.28 +/- 0.14 hr. A comparison of the spectrophotometric method with the HPLC method yielded a correlation coefficient of 0.98. The HPLC assay for antipyrine is rapid and precise and can be used for hepatic drug metabolism study in a single animal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480161     DOI: 10.1002/jps.2600680835

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma.

Authors:  A el-Yazigi; D A Raines; H Ali; J Sieck; P Ernst; M Dossing
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

2.  Relationships among liver and kidney volumes, lean body mass and drug clearance.

Authors:  S Nawaratne; J E Brien; E Seeman; R Fabiny; J Zalcberg; W Cosolo; P Angus; D J Morgan
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

3.  Cisapride has no effect on antipyrine clearance.

Authors:  D S Davies; F J Mills; P J Welburn
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

4.  Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.

Authors:  D Vital Durand; C Hampden; A R Boobis; B K Park; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

5.  Impaired elimination of metronidazole in decompensated chronic liver disease.

Authors:  G Farrell; L Zaluzny; J Baird-Lambert; M Cvejic; N Buchanan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

6.  Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine.

Authors:  J M Connell; W G Rapeport; S Gordon; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Effect of stanozolol on delta-aminolaevulinic acid synthase and hepatic monooxygenase activity in man and rat.

Authors:  G G Thompson; M Small; G D Lowe; C D Forbes; B K Park; G Scobie; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine.

Authors:  W G Rapeport; G T McInnes; G G Thompson; G Forrest; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

9.  Antipyrine kinetics in undernourished diabetics.

Authors:  J C Shobha; T C Raghuram; A D Kumar; K Krishnaswamy
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Accuracy and clinical utility of simplified tests of antipyrine metabolism.

Authors:  G C Farrell; L Zaluzny
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.